Pathological mechanisms in progressive multiple sclerosis
Top Cited Papers
- 1 February 2015
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 14 (2), 183-193
- https://doi.org/10.1016/s1474-4422(14)70256-x
Abstract
No abstract availableKeywords
Funding Information
- National Multiple Sclerosis Society
- Austrian Science Fund
- National Institutes of Health
- U.S. Department of Defense
This publication has 100 references indexed in Scilit:
- Inflammatory Cortical Demyelination in Early Multiple SclerosisThe New England Journal of Medicine, 2011
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisNature, 2011
- Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulinJournal of Neuroimmunology, 2011
- Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patientsAnnals of Neurology, 2010
- Mitochondrial DNA deletions and neurodegeneration in multiple sclerosisAnnals of Neurology, 2010
- Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte deathBrain, 2010
- The relation between inflammation and neurodegeneration in multiple sclerosis brainsBrain, 2009
- Mitochondrial changes within axons in multiple sclerosisBrain, 2009
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- Docking of Axonal Mitochondria by Syntaphilin Controls Their Mobility and Affects Short-Term FacilitationCell, 2008